Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors

Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the appointment of Andrew Levin, M.D., Ph.D., ...
FierceBiotech

Fresh from early successes, RA Capital bags $461M for new fund

RA Capital Management has raised another $461 million to invest in private biotechs. The closing of the fund comes 15 months after RA Capital set up an inaugural venture fund that has already seen 25% ...
BioPharma Dive

RA Capital backs drug for rare kind of chronic pain

The investment firm co-led a $125 million Series A round for Ambros Therapeutics, a Vivek Ramaswamy co-founded company with a ...
Fierce Biotech

Ramaswamy-backed Ambros Therapeutics launches with $125M to develop pain drug

Vivek Ramaswamy has found time out of his campaign for governor of Ohio to launch a new biotech.  | Vivek Ramaswamy has found ...
Morningstar

RA Capital Management Funds Expansion of ARS Pharma Commercial Activity, Expands Portfolio of Financing Solutions for Innovative Healthcare Companies

– RA Capital and OMERS Life Sciences provide up to $250 million loan facility to commercial-stage biopharma company ARS Pharma to propel further growth – BOSTON, Sept. 30, 2025 /PRNewswire/ -- RA ...
Investing

RA Capital funds sell $3.4m in Vor Biopharma (VOR) stock

RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P. and related parties, including Peter Kolchinsky and Rajeev M. Shah, sold 116,046 shares of Vor Biopharma Inc. NASDAQ:VOR common stock on ...
Nasdaq

RA Capital Launches Structured Capital Solutions

Leading Healthcare-Focused Investor Expands Capabilities to Provide Comprehensive Suite of Equity, Debt, Royalty, and Hybrid Financing Solutions for Commercial Stage Companies Industry Veterans Jeremy ...
Insider Monkey

15 Pharmaceutical Stocks to Buy According to Peter Kolchinsky’s RA Capital

In this piece, we will take a look at the top 15 pharmaceutical stocks to buy according to Peter Kolchinsky’s RA Capital. If you want to skip our introduction and take a look at the top five stocks in ...
Business Insider

Only a handful of psychedelics companies have gotten funding from established biotech investors. Here's what they've done right, according to a top VC.

RA Capital is one of the few mainstream biotech VCs wading into the psychedelics space. The VC firm has invested in three psychedelics startups since 2021. It's looking for companies with short acting ...
Business Wire

Atlas Venture, F-Prime Capital, RA Capital Management, and Osage University Partners to Host Second Annual Science2Startup Symposium

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Life science-focused venture capital firms Atlas Venture, F-Prime Capital, RA Capital Management, and Osage University Partners (OUP) have partnered to create ...
MedCity News

RA Capital Management closes $308M venture capital fund

A firm that invests in healthcare and life sciences has raised more than a quarter of $1 billion for a new venture fund. Boston-based RA Capital Management said Monday that it had closed its inaugural ...
Business Insider

A top biotech VC and a Juno alum just launched a $145 million startup to take a new approach to chronic pain and depression

Eliem Therapeutics is launching with two drugs that are already in human tests for chronic pain and depression. The biotech was formed from two startups RA Capital has been incubating. It is part of a ...